Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth

Xiaoyu Hu1, Pranabananda Dutta, Amy Tsurumi

  • 1Department of Biomedical Genetics, University of Rochester Medical Center, Rochester, NY 14642, USA.

Insights

Unphosphorylated STAT5A acts as a novel tumor suppressor by forming heterochromatin to repress oncogenes. This epigenetic mechanism inhibits colon cancer growth and is disrupted in human cancers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Traditional tumor suppressors halt cancer by cell cycle arrest or apoptosis.
  • The role of STAT5A in tumor suppression, particularly its unphosphorylated form, remains largely unexplored.

Purpose of the Study:

  • To investigate the function of unphosphorylated STAT5A as a tumor suppressor.
  • To elucidate the mechanism by which unphosphorylated STAT5A represses oncogenes.
  • To assess the therapeutic potential of unphosphorylated STAT5A and HP1α in cancer models.

Main Methods:

  • Investigated the interaction between unphosphorylated STAT5A and heterochromatin protein 1α (HP1α).
  • Utilized mouse xenograft models to evaluate the impact of unphosphorylated STAT5A and HP1α on colon cancer growth.
  • Performed transcriptome profiling to analyze gene expression changes induced by unphosphorylated STAT5A.

Main Results:

  • Unphosphorylated STAT5A functions as a tumor suppressor by forming heterochromatin and repressing oncogenes.
  • Unphosphorylated STAT5A binds to and stabilizes heterochromatin protein 1α (HP1α).
  • Expression of unphosphorylated STAT5A or HP1α significantly inhibited colon cancer growth in vivo.
  • Genes commonly repressed by unphosphorylated STAT5A and HP1α are frequently implicated in cancer development.
  • Down-regulation, mutations, and deletions of STAT5 genes were observed in human cancers.

Conclusions:

  • Unphosphorylated STAT5A epigenetically suppresses tumor growth through heterochromatin formation.
  • STAT5A and HP1α represent potential therapeutic targets for cancer treatment.
  • Disruption of STAT5 genes contributes to the development of certain human cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...